Private Capital Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1K Buy
33
+13
+65% +$552 ﹤0.01% 1782
2022
Q1
$1K Sell
20
-22
-52% -$1.58K ﹤0.01% 2003
2021
Q4
$4K Buy
42
+9
+27% +$1.08K ﹤0.01% 1632
2021
Q3
$4K Buy
33
+2
+6% +$291 ﹤0.01% 1677
2021
Q2
$5K Sell
31
-89
-74% -$14.4K ﹤0.01% 1572
2021
Q1
$22K Sell
120
-126
-51% -$29.2K 0.01% 1030
2020
Q4
$49K Sell
246
-62
-20% -$12.6K 0.01% 800
2020
Q3
$68K Buy
308
+11
+4% +$2.33K 0.01% 594
2020
Q2
$57K Sell
297
-16
-5% -$2.8K 0.01% 652
2020
Q1
$49K Buy
313
+113
+57% +$13.1K 0.01% 649
2019
Q4
$16K Hold
200
﹤0.01% 1192
2019
Q3
$14K Buy
+200
New +$13.2K ﹤0.01% 1343
2019
Q2
Sell
-200
Closed -$11K 2413
2019
Q1
$11K Buy
+200
New +$12.2K ﹤0.01% 1447

Other funds holding TDOC

Private Capital Group's TDOC Position: Q2 2022 in Review

Private Capital Group increased its Teladoc Health (TDOC) stake by 65% in Q2 2022, buying an estimated $552 and bringing the position to 33 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1782.

Private Capital Group first reported a position in TDOC in Q1 2019 and has held it in 13 quarters since. The position peaked at $68K in Q3 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Private Capital Group held 33 shares of Teladoc Health worth $1K as of Q2 2022.
  • Private Capital Group bought 13 Teladoc Health shares in Q2 2022, an estimated $552.
  • Teladoc Health made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1782 holding.
  • Private Capital Group first reported a position in Teladoc Health in Q1 2019 and has held it in 13 quarters since.
  • Private Capital Group's Teladoc Health position peaked at $68K in Q3 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.